Andrew Dudum - 01 Mar 2023 Form 4/A - Amendment Insider Report for Hims & Hers Health, Inc. (HIMS)

Signature
/s/ Alexandra Cotter Wilkins, Attorney-in-Fact
Issuer symbol
HIMS
Transactions as of
01 Mar 2023
Net transactions value
-$348,746
Form type
4/A - Amendment
Filing time
17 Mar 2023, 16:17:29 UTC
Date Of Original Report
03 Mar 2023
Previous filing
19 Dec 2022
Next filing
07 Mar 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HIMS Class A Common Stock Options Exercise $89,018 +36,633 +10% $2.43 387,248 01 Mar 2023 Direct F1
transaction HIMS Class A Common Stock Sale $437,764 -36,633 -9.5% $11.95 350,615 01 Mar 2023 Direct F1, F2
holding HIMS Class A Common Stock 1,500 01 Mar 2023 Held by Trustees of Richard M. Dudum Irrevocable 1 U/A dtd 10/15/1997
holding HIMS Class A Common Stock 81,100 01 Mar 2023 Held by Trustee of Dudum Family Community Property Trust
holding HIMS Class A Common Stock 700,000 01 Mar 2023 Held by Trustee of AD 2022 GRAT
holding HIMS Class A Common Stock 359,947 01 Mar 2023 Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015
holding HIMS Class A Common Stock 1,695,815 01 Mar 2023 Held by Trustee of AD 2022 GRAT 3
holding HIMS Class A Common Stock 2,874,769 01 Mar 2023 Held by Trustee of Dudum Family Heritage Trust UAD 8-10-2021
holding HIMS Class A Common Stock 660,837 01 Mar 2023 Held by Trustee of AD 2021 GRAT 2 dated 11-1-2021
holding HIMS Class A Common Stock 2,643,348 01 Mar 2023 Held by Trustee of AD 2021 GRAT dated 11-1-2021
holding HIMS Class A Common Stock 1,047,164 01 Mar 2023 Held by Trustee of AD 2022 GRAT 2 dated 9/7/2022
holding HIMS Class A Common Stock 1,121,033 01 Mar 2023 Held by Trustee of the AD GRAT dated 8/31/20

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HIMS Stock Option (right to buy) Options Exercise $0 -36,633 -1.1% $0.000000 3,209,506 01 Mar 2023 Class A Common Stock 36,633 $2.43 Direct F3
transaction HIMS Restricted Stock Unit Award $0 +567,144 $0.000000 567,144 01 Mar 2023 Class A Common Stock 567,144 $0.000000 Direct F4
transaction HIMS Stock Option (right to buy) Award $0 +214,461 $0.000000 214,461 01 Mar 2023 Class A Common Stock 214,461 $11.53 Direct F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 3, 2022 by the Reporting Person.
F2 Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $11.95 - $12.02. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F3 Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021.
F4 The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2023.
F5 The exercise price of the options awarded has been adjusted from the original filing due to administrative error.
F6 The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting monthly, beginning on April 1, 2023.